933 related articles for article (PubMed ID: 11287583)
21. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
23. Construction of replication-defective herpes simplex virus vectors.
Goins WF; Marconi P; Krisky D; Wolfe D; Glorioso JC; Ramakrishnan R; Fink DJ
Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.11. PubMed ID: 18428322
[TBL] [Abstract][Full Text] [Related]
24. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
[TBL] [Abstract][Full Text] [Related]
25. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.
Howard MK; Kershaw T; Gibb B; Storey N; MacLean AR; Zeng BY; Tel BC; Jenner P; Brown SM; Woolf CJ; Anderson PN; Coffin RS; Latchman DS
Gene Ther; 1998 Aug; 5(8):1137-47. PubMed ID: 10326038
[TBL] [Abstract][Full Text] [Related]
26. Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system.
Gao Q; Sun M; Wang X; Zhang GR; Geller AI
Brain Res; 2006 Apr; 1083(1):1-13. PubMed ID: 16545782
[TBL] [Abstract][Full Text] [Related]
27. Enhanced long-term expression from helper virus-free HSV-1 vectors packaged in the presence of deletions in genes that modulate the function of VP16, U L 46 and U L 47.
Liu M; Tang J; Wang X; Yang T; Geller AI
J Neurosci Methods; 2005 Jun; 145(1-2):1-9. PubMed ID: 15922021
[TBL] [Abstract][Full Text] [Related]
28. Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice.
Mitchell WJ
J Virol; 1995 Dec; 69(12):7942-50. PubMed ID: 7494307
[TBL] [Abstract][Full Text] [Related]
29. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
[TBL] [Abstract][Full Text] [Related]
30. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
Warden MP; Weir JP
Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions.
Song B; Yeh KC; Liu J; Knipe DM
Virology; 2001 Nov; 290(2):320-8. PubMed ID: 11883196
[TBL] [Abstract][Full Text] [Related]
32. Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice.
Loiacono CM; Myers R; Mitchell WJ
J Virol; 2002 Mar; 76(5):2449-59. PubMed ID: 11836423
[TBL] [Abstract][Full Text] [Related]
33. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22.
Wu N; Watkins SC; Schaffer PA; DeLuca NA
J Virol; 1996 Sep; 70(9):6358-69. PubMed ID: 8709264
[TBL] [Abstract][Full Text] [Related]
34. In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.
Speck PG; Efstathiou S; Minson AC
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2563-8. PubMed ID: 8887491
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
[TBL] [Abstract][Full Text] [Related]
36. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
Lachmann RH; Efstathiou S
J Virol; 1997 Apr; 71(4):3197-207. PubMed ID: 9060683
[TBL] [Abstract][Full Text] [Related]
37. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
38. Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors.
Weir JP; Dacquel EJ
Gene; 1995 Feb; 154(1):123-8. PubMed ID: 7867939
[TBL] [Abstract][Full Text] [Related]
39. Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27.
Ellison KS; Maranchuk RA; Mottet KL; Smiley JR
J Virol; 2005 Apr; 79(7):4120-31. PubMed ID: 15767413
[TBL] [Abstract][Full Text] [Related]
40. Differential effects on the survival of neuronal and non-neuronal cells after infection by herpes simplex virus type 1 mutants.
Garrido JJ; Carnicero E; Lim F; Schimmang T
J Neurovirol; 1999 Jun; 5(3):280-8. PubMed ID: 10414518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
